Get the app
US › Healthcare

OKYO Pharma Limited (OKYO)

US · Healthcare · Biotechnology

$1.41-1.40%
Last close · 2026-10-16

Key statistics

Market cap
$74.0M
Forward P/E
0.0
P/B
5.53
Book value
$0.23
EPS (TTM)
$-0.24
52-week high
$3.20
52-week low
$1.26
50-day MA
$1.46
200-day MA
$1.68
Beta
-0.06

Analyst view

Analysts rate OKYO Pharma Limited a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $8.33.

Shareholding

Insiders
31.13%
Institutions
20.10%

Largest institutional holders

FundStake
Woodline Partners LP6.96%
Stonepine Capital Management Llc1.64%
MAVEN SECURITIES Ltd1.54%
Balyasny Asset Management LLC1.11%
Opaleye Management Inc0.71%
UBS Group AG0.10%
XTX Topco Ltd0.07%
Quantinno Capital Management LP0.06%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OKYO Pharma Limited — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.